NanoViricides Statistics
Share Statistics
NanoViricides has 15.64M
shares outstanding. The number of shares has increased by 32.39%
in one year.
| Shares Outstanding | 15.64M |
| Shares Change (YoY) | 32.39% |
| Shares Change (QoQ) | 9.02% |
| Owned by Institutions (%) | 10% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2,901 |
| FTD / Avg. Volume | 1.82% |
Short Selling Information
The latest short interest is 330.88K, so 2.12% of the outstanding
shares have been sold short.
| Short Interest | 330.88K |
| Short % of Shares Out | 2.12% |
| Short % of Float | 2.2% |
| Short Ratio (days to cover) | 2.54 |
Valuation Ratios
The PE ratio is -2.65 and the forward
PE ratio is -1.12.
NanoViricides's PEG ratio is
0.49.
| PE Ratio | -2.65 |
| Forward PE | -1.12 |
| PS Ratio | 0 |
| Forward PS | 3.1 |
| PB Ratio | 1.92 |
| P/FCF Ratio | -3.39 |
| PEG Ratio | 0.49 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for NanoViricides.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.66,
with a Debt / Equity ratio of 0.
| Current Ratio | 3.66 |
| Quick Ratio | 3.66 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -170.98 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,184,878 |
| Employee Count | 7 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -24.04% in the
last 52 weeks. The beta is 0.95, so NanoViricides's
price volatility has been higher than the market average.
| Beta | 0.95 |
| 52-Week Price Change | -24.04% |
| 50-Day Moving Average | 1.25 |
| 200-Day Moving Average | 1.46 |
| Relative Strength Index (RSI) | 59.56 |
| Average Volume (20 Days) | 159,247 |
Income Statement
| Revenue | n/a |
| Gross Profit | -759.01K |
| Operating Income | -8.52M |
| Net Income | -8.29M |
| EBITDA | -7.76M |
| EBIT | -8.52M |
| Earnings Per Share (EPS) | -0.7 |
Full Income StatementBalance Sheet
The company has 4.8M in cash and 0 in
debt, giving a net cash position of 4.8M.
| Cash & Cash Equivalents | 4.8M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -139.37M |
| Total Assets | 11.57M |
| Working Capital | 2.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -6.32M
and capital expenditures -156.56K, giving a free cash flow of -6.47M.
| Operating Cash Flow | -6.32M |
| Capital Expenditures | -156.56K |
| Free Cash Flow | -6.47M |
| FCF Per Share | -0.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
